Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Unknown 2Terminated 2Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 12Head & Neck 11Gynecologic 11Other hematologic neoplasm 7Genitourinary 7Lymphoid 5Breast 5Sarcoma 4Other solid neoplasm 3CNS 3Plasma cell 2Myeloid 2Gastrointestinal 2Dermatologic 2Classical hematology 2Other 1

Conditions

Rectal Neoplasms 1Hepatoblastoma 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 331Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Amifostine × Gastrointestinal × Clear all
NCT00003225 2020-08-03

Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Jonsson Comprehensive Cancer Center

Phase 1/2 Completed
23 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00003994 2013-06-14

Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer

Children's Oncology Group

Phase 3 Completed
277 enrolled
Gastrointestinal

Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡